1,334
Participants
Start Date
November 9, 2012
Primary Completion Date
April 20, 2017
Study Completion Date
January 20, 2026
brentuximab vedotin
Brentuximab vedotin (ADCETRIS®)1.2 mg/kg by IV infusion on Days 1 and 15 of each 28-day cycle.
doxorubicin
Doxorubicin: 25 mg/m\^2 by IV infusion on Days 1 and 15 of each 28-day cycle.
bleomycin
Bleomycin: 10 units/m\^2 by IV infusion on Days 1 and 15 of each 28-day cycle.
vinblastine
Vinblastine: 6 mg/m2 will be administered by IV infusion on Days 1 and 15 of each 28-day cycle
dacarbazine
Dacarbazine (DTIC): 375 mg/m\^2 by IV infusion on Days 1 and 15 of each 28-day cycle.
Birmingham
Gilbert
Tucson
Burbank
Duarte
Fresno
Fullerton
La Jolla
Long Beach
Los Angeles
Sacramento
San Luis Obispo
Santa Barbara
Santa Monica
Stanford
Colorado Springs
Denver
Lonetree
Washington D.C.
Fort Myers
Jacksonville
Miami
Orlando
Lawrenceville
Chicago
Maywood
Niles
Zion
Fort Wayne
Goshen
Indianapolis
Iowa City
Fairway
Baltimore
Bethesda
Boston
Ann Arbor
Detroit
Minneapolis
Rochester
Springfield
St Louis
Lincoln
Omaha
Las Vegas
Basking Ridge
Hackensack
Morristown
Albuquerque
Albany
Commack
New York
Rochester
Rockville Centre
The Bronx
Charlotte
Raleigh
Bismarck
Cincinnati
Columbus
Oklahoma City
Eugene
Hershey
Philadelphia
Charleston
Greenville
Chattanooga
Knoxville
Nashville
Austin
Dallas
Houston
San Antonio
Tyler
Salt Lake City
Fairfax
Richmond
Kennewick
Seattle
Vancouver
Yakima
Morgantown
Milwaukee
Kingswood
St Leonards
Westmead
South Brisbane
Bedford Park
Hobart
East Melbourne
Geelong
Heidelberg
Parkville
Perth
Antwerp
Bruges
Ghent
Salvador
Curitiba
Porto Alegre
Santo André
Rio de Janeiro
São Paulo
Edmonton
Vancouver
Winnipeg
Halifax
Toronto
Montreal
Saskatoon
Hradec Králové
Prague
Aalborg
Aarhus C
Copenhagen
Odense C
Roskilde
Argenteuil
La Tronche
Limoges
Paris
Lai Chi Kok
Hong Kong
Tuenmen
Budapest
Debrecen
Győr
Pécs
Szeged
Modena
Rome
Alessandria
Bologna
Cagliari
Cuneo
Genova
Milan
Napoli
Rionero in Volture
Rome
Rozzano
Torrette Di Ancona
Higashiku
Minamiku
Minamiku
Shōwamachi
Chikusa-ku
Suita
Aoba-ku
Chūōku
Isehara-shi
Kōtoku
Bergen
Oslo
Gdansk
Katowice
Krakow
L0dz
Olsztyn
Warsaw
Wroclaw
Ufa
Saint Petersburg
Kazan'
Moscow
Moskva
Saint Petersburg
Johannesburg
Pretoria
eManzimtoti
Bloemfontein
Cape Town
Goyang-si
Hwasun-gun
Seocho-gu
Busan
Daegu
Incheon
Jeonju
Seoul
Badalona
Barcelona
Marbella
Pamplona
Salamanca
Santiago de Compostela
Valencia
Changhua
Chiayi County 613
Tainan City
Taipei
Taoyuan
Ankara
Istanbul
Samsun
Truro
Aberdeen
Glasgow
Sutton
Cardiff
Birmingham
Canterbury
Exeter
Inverness
Leicester
Lincoln
Liverpool
London
Manchester
Norfolk
Northwood
Nottingham
Oxford
Romford
Southampton
Lead Sponsor
Seagen Inc.
INDUSTRY
Takeda
INDUSTRY